So rather than several months it took just several weeks (well around six weeks) for Swiss pharmaceutical giant Novartis to return with a proper takeover offer for Avidity Biosciences, the US-listed biotechnology company.
Back in early August hacks at the Financial Times ran with the Avidity Biosciences takeover rumour that was circulating European markets.
Hacks at the Financial Times have decided to run the Avidity Biosciences takeover tale that has been circulating around for the last couple of weeks.
Finanz und Wirtschaft has waded into the Incyte Corporation takeover rumour story first aired on little old Betaville several weeks ago.
Dominic "Dom" Walsh is at it again.